POMA, Paola
 Distribuzione geografica
Continente #
NA - Nord America 5.185
EU - Europa 2.758
AS - Asia 1.082
SA - Sud America 279
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 9.357
Nazione #
US - Stati Uniti d'America 5.152
IT - Italia 1.021
FI - Finlandia 466
SG - Singapore 413
CN - Cina 406
UA - Ucraina 376
BR - Brasile 254
DE - Germania 233
IE - Irlanda 188
GB - Regno Unito 132
SE - Svezia 99
TR - Turchia 66
IN - India 60
RU - Federazione Russa 60
FR - Francia 48
BE - Belgio 34
NL - Olanda 20
CI - Costa d'Avorio 18
HK - Hong Kong 18
RO - Romania 18
IR - Iran 15
KR - Corea 15
BG - Bulgaria 12
CA - Canada 12
MX - Messico 11
AT - Austria 10
CH - Svizzera 10
CZ - Repubblica Ceca 9
EG - Egitto 9
MY - Malesia 9
IQ - Iraq 8
UZ - Uzbekistan 8
VN - Vietnam 8
PK - Pakistan 7
SY - Repubblica araba siriana 6
TN - Tunisia 6
AR - Argentina 5
KZ - Kazakistan 5
MA - Marocco 5
AZ - Azerbaigian 4
BD - Bangladesh 4
CL - Cile 4
ES - Italia 4
JP - Giappone 4
LB - Libano 4
UY - Uruguay 4
EU - Europa 3
GR - Grecia 3
LT - Lituania 3
MT - Malta 3
PE - Perù 3
PH - Filippine 3
PL - Polonia 3
SA - Arabia Saudita 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
LY - Libia 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
ID - Indonesia 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NI - Nicaragua 1
OM - Oman 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 9.357
Città #
Fairfield 699
Ashburn 416
Chandler 403
Houston 385
Woodbridge 373
Ann Arbor 331
Palermo 307
Wilmington 296
Singapore 258
Seattle 255
Cambridge 222
Jacksonville 207
Dublin 183
Medford 136
Des Moines 129
Nanjing 89
Princeton 85
Boardman 78
Altamura 62
New York 57
Santa Clara 55
Tulsa 55
Beijing 49
Lawrence 48
San Diego 48
The Dalles 44
Dearborn 43
Helsinki 33
Brussels 32
Venice 32
Izmir 31
Milan 29
Nanchang 28
Hebei 27
Ludwigshafen am Rhein 27
Shenyang 27
Bremen 25
Changsha 21
Abidjan 18
Falls Church 18
Jinan 18
London 18
Los Angeles 18
Rome 17
Council Bluffs 15
Messina 15
Hong Kong 14
Jiaxing 14
Ningbo 14
San Paolo di Civitate 14
Seongnam 14
Verona 14
Kumar 13
São Paulo 13
Saint Petersburg 12
Auburn Hills 11
Belo Horizonte 11
Rio de Janeiro 11
Sofia 11
Catania 10
Munich 10
Zhengzhou 10
Bologna 9
Guangzhou 9
Napoli 9
Nuremberg 9
Salerno 9
San Mateo 9
Brescia 8
Columbus 8
Hangzhou 8
Taizhou 8
Tianjin 8
Brasília 7
Capaci 7
Naples 7
Pune 7
Sanayi 7
Tashkent 7
Berlin 6
Durham 6
Frankfurt am Main 6
Kilburn 6
Kunming 6
New Delhi 6
Redwood City 6
Renton 6
Shanghai 6
Atlanta 5
Bengaluru 5
Campinas 5
Haikou 5
Lahore 5
Lanzhou 5
Lappeenranta 5
Nha Trang 5
Norwalk 5
San Giuliano Milanese 5
Toronto 5
Andover 4
Totale 6.207
Nome #
Targeting Multiple Myeloma with natural polyphenols 216
Chemical and pharmaceutical evaluation of the relationship between triazole linkers and pore size on cyclodextrin–calixarene nanosponges used as carriers for natural drugs 208
ANTITUMOR EFFECTS OF CURCUMIN, ALONE OR IN COMBINATION WITH CISPLATIN OR DOXORUBICIN, ON HUMAN HEPATIC CANCER CELLS. ANALYSIS OF THEIR POSSIBLE RELATIONSHIP TO CHANGES IN NF-KB ACTIVATION LEVELS AND IAP GENE EXPRESSION 202
Chemical Composition, In Vitro Antitumor and Pro-Oxidant Activities of Glandora rosmarinifolia (Boraginaceae) Essential Oil 193
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 187
Antitumor mechanism of the essential oils from two succulent plants in multidrug resistance leukemia cell 186
Pharmaceutical properties of supramolecular assembly of co-loaded cardanol/triazole-halloysite systems 185
Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels 179
Essential oil of Cyphostemma juttae (Vitaceae): chemical composition and antitumor mechanism in triple negative breast cancer cells 179
Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity. 177
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 173
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 170
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells 167
Expression of the IAPs in multidrug resistant tumor cells 163
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma 157
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells 153
The antitumor activities of curcumin and its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 brest cancer cell line: Analysis of the possible molecular basis. 147
Multifactorial nature of hepatocellular carcinoma drug resistance: Could plant polyphenols be helpful? 146
Direct chemical grafted curcumin on halloysite nanotubes as dual-responsive prodrug for pharmacological applications 140
Unusual high dose of tacrolimus in liver transplant patient, a case report. 138
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors 138
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients. 137
Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement 137
Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models 137
Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines 133
NF-kB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers 130
Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 129
Effetti della curcumina e di suoi analoghi modificati al frammento beta-dichetone in cellule tumorali multifarmacoresistenti. 125
Pro-oxidant and antitumor effects of curcumin and N-ethylmaleimide in the HA22T/VGH model Overt hepatocellular carcinoma. 125
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”. 124
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities. 121
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 121
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients 118
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View 117
Co-loaded cardanol/triazole-halloysite system: characterization of the supramolecular complex and evaluation of its antiproliferative activity 115
Apollon gene silencing induces apoptosis in breast cancer cells via p53 stabilisation and caspase-3 activation 113
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma 112
Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma 110
In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R 107
Chemical and biological evaluation of cross-linked halloysite-curcumin derivatives 106
Meccanismi antitumorali degli oli essenziali estratti da piante succulente in un modello di leucemia mielocitica acuta multifarmacoresistente 105
Phytol and heptacosane: the two major components of Euphorbia intisy essential oil with biological activities in drug resistant leukemia cell. 105
Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possibile relationship to the effects on inhibitor of apoptosis protein levels 104
Rash and multiorgan dysfunction following lamotrigine: could genetic be involved? 104
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 103
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers. 102
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 101
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients 100
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells 89
“Antitumor and molecular effects of curcumin and of its isoxazole analogue on multidrug resistant breast cancer cells. New perspectives in tumor theraphy: molecular aspects, 2006”. 88
Plant polyphenols as possible lead compound against hormone-independent multidrug resistant breast cancer. 87
Antitumor effects of curcumin in human hepatic cancer cells: Analysis of their relationship to inhibition of NF-kB and pro-survival gene expression. 86
Antitumor effects of the grape stilbenes resveratrol and piceatannol on multidrug and apoptosis resistant HL60 leukemia cells" 85
Antitumor effects of curcumin, alone or in combination with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production 85
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combined with cisplatin, on hepatic cancer cells. analysis of their relationship to IL-6 production. 83
Caratterizzazione e valutazione dell’attività anti proliferativa di nuovi sistemi per il drug carrier Allosite-sali triazolici/cardanolo 80
Significance of Autologous Interleukin-6 Production in the HA22T/VGH Cell Model of Hepatocellular Carcinoma 80
The antitumor activities of curcumin and of its novel isoxazole analogue MR 39 are not hampered by the multidrug resistant condition of tumor cells expressing both P-glycoprotein and different inhibitory of apoptosis proteins 79
ELABORATION OF CURCUMIN INTO DIKETONE MODIFIED ANALOGUES DEVOID OF NUCLEOPHILIC ADDITION CAPABILITY; IMPLICATIONS FOR THEIR ANTITUMOR AND CHEMOSENSITIZING ACTIVITIES 78
Prodrug based on halloysite delivery systems to improve the antitumor ability of methotrexate in leukemia cell lines 78
SYNTHESIS AND CHARACTERIZATION OF POSITIVELY CHARGED FUNCTIONALIZED HALLOYSITE/CURCUMIN SYSTEMS AND EVALUATION OF THEIR ANTICANCER ACTIVITY 77
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil. 76
Le attività antitumorali della curcumina e del suo più potente analogo isossazolico non sono compromesse dal pattern di espressione genica della variante MDR della linea di carcinoma mammario MCF-7 75
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms 74
Effetti della curcumina e del suo derivato isossazolico in modelli di neoplasia multifarmacoresistente 72
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia 71
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma 70
Antitumor effects of curcumin and of its combinations with cisplatin or doxorubicin on human hepatic cancer cells: Possible relationship to NF-kB activation and IAP gene expression 68
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines 67
Antitumor effects of curcumin and of its combination with cisplatin or doxorubicin on human hepatic cancer cells: possible relationship to NF-kB activation and IAP gene expression. 67
DISTRIBUTION OF CYP3A5 AND MDR-1 SINGLE NUCLEOTIDE POLYMORPHISMS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 67
THE EFFECT OF CYP3A5 AND ABCB1 SINGLE NUCLEOTIDE POLYMORPHISMS ON TACROLIMUS DOSE REQUIREMENTS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 67
null 67
Effects of curcumin and related analogues on tumor cell lines expressing multiple mechanisms of drug resistance 66
Inhibitor of apoptosis proteins (IAPs) as new possible therapeutic targets in hepatocellular cancer 66
Restoration of Raf-1 Kinase Inhibitor Protein levels as a possible therapeutic approach in hepatocellular carcinoma. 65
Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma 65
Ihnibitor of Apoptosis Proteins (IAPs) as a new possible therapeutic targets in hepatocellular cancer. 64
Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway 62
New trends in overcoming drug resistance in hepatocellular carcinoma. Looking for pharmacological inhibition of Inhibitory of Apoptosis Proteins (IAPs) by curcumin. 60
Effects of the dietary polyphenols resveratrol and curcumin on the prevention and treatment of cancer. 58
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 56
NF-κB is a potential pharmacological target in triple negative breast cancers. 54
Natural Inhibitors of P-glycoprotein in AcuteMyeloid Leukemia 53
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 52
Plant polyphenols as privileged multi-target compounds for chemo- and immuno-sensitization 52
Alteration of the YY1/RKIP ratio is a frequent event in hepatocellular carcinoma 48
Exploring the cellular uptake of hectorite clay mineral and its drug carrier capabilities 47
NF-kB and Disease 46
Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It 46
Antitumor Effect of Glandora rosmarinifolia (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid Leukemia 46
MDA-9/Syntenin-NF-κB-RKIP loop in triple negative breast cancers (TNBC) and human liver carcinoma 43
Antimigratory effects of a new NF-κB inhibitor, (S)-b-salicyloylamino-a-exo-methylene-ƴ-butyrolactone, in 2D and 3D breast cancer models 32
PLLA Porous Scaffold as a 3D Breast Cancer Model to Investigate Drug Resistance 27
A Curcumin-BODIPY Dyad and Its Silica Hybrid as NIR Bioimaging Probes 25
Vesicle-Transported Multidrug Resistance as a Possible Therapeutic Target of Natural Compounds 20
Epigenetic and Cellular Reprogramming of Doxorubicin-Resistant MCF-7 Cells Treated with Curcumin 15
Totale 9.829
Categoria #
all - tutte 38.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.004


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020310 0 0 0 0 0 0 0 0 0 107 117 86
2020/20211.124 42 107 55 120 84 60 84 83 137 99 146 107
2021/20221.172 50 236 32 21 57 37 72 41 117 197 77 235
2022/20231.335 140 209 22 155 161 217 107 84 147 14 65 14
2023/2024692 50 98 50 27 38 137 48 48 14 36 40 106
2024/20251.489 43 185 111 193 124 82 196 141 189 225 0 0
Totale 9.829